Steel and mining company ArcelorMittal (OTCPK:AMSYF) announced on Friday the sale of its operations in Bosnia and Herzegovina ...

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Eli Lilly LLY -1.05% ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Tate McRae’s makeup artist, Lilly Keys, shares the secrets behind the singer’s looks, and reveals her favorite products and how she gets red-carpet ready.

Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Both ...

Bernstein SocGen Group has reiterated an Outperform rating and $1,100.00 price target on Eli Lilly (NYSE: LLY) ahead of the American Diabetes Association’s 85th Annual meeting.Currently trading ...

Eli Lilly (LLY) ended the recent trading session at $807.58, demonstrating a -1.44% change from the preceding day's closing price. This change lagged the S&P 500's 0.94% gain on the day. At the ...

Four-year-old Jack Sullivan and six-year-old Lilly Sullivan were reported missing on May 2, 2025 in the community of ...

Eli Lilly (NYSE: LLY) stock hasn't been doing too well this year, but that could change later this month. If Eli Lilly ...

Novo Nordisk (NVO), and Amgen (NASDAQ:AMGN) are scheduled to present major clinical trial readouts at the American Diabetes ...

A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose up to 1.5%.